Table 2.
Relative proangiogenic factor transcript levels in treated and untreated mice at D3 (N = 5–8).
| Transcript | PBS | PB-MNC | PB-MNC+ | P values |
|---|---|---|---|---|
| Ang-1 | 0.7 ± 0.4 | 0.9 ± 0.3 | 1.0 ± 0.3 | 0.42 |
| Ang-2 | 0.8 ± 0.4 | 0.9 ± 0.5 | 0.9 ± 0.6 | 0.99 |
| Tie 2 | 1.2 ± 0.4 | 1.2 ± 0.6 | 1.8 ± 1.4 | 0.84 |
| eNOS | 0.5 ± 1.6 | 0.9 ± 0.6 | 1.0 ± 0.6 | 0.40 |
| VEGF-A | 0.6 ± 1.2 | 0.9 ± 0.6 | 0.9 ± 0.8 | 0.79 |
| VEGFR-2 | 0.7 ± 0.3 | 0.9 ± 0.5 | 1.0 ± 0.4 | 0.55 |
| PDGF-B | 2.5 ± 1.3 | 2.6 ± 0.6 | 2.4 ± 0.6 | 0.75 |
| PDGFR-1 | 0.6 ± 0.2 | 1.0 ± 0.3 | 1.0 ± 0.6 | 0.07 |
| TGF-β | 0.7 ± 0.3 | 0.9 ± 0.3 | 1.2 ± 0.4 | P < 0.05 |
| TGFR-2 | 3.7 ± 0.4 | 4.3 ± 1.6 | 3.2 ± 1.3 | 0.62 |
Ang-1: angiopoietin-1; Ang-2: angiopoietin-2; Tie-2: angiopoietin tyrosine kinase receptor; eNOS: endothelial nitric oxide synthase; VEGF-A: vascular endothelial factor-A; VEGFR-2: VEGF receptor-2; PDGF-B: platelet-derived growth factor-B; PDGFR-1: PDGF receptor-1; TGF-β: transforming growth factor-β; TGFR-2: transforming growth factor-β receptor-2. Data are presented as mean (arbitrary units) ± SD.